Lebwohl, MG, J Sugarman, DM Pariser, J Bagel, T Lin, and R Israel. 2020. “Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study”. SKIN The Journal of Cutaneous Medicine 4 (1):S12. https://www.jofskin.org/index.php/skin/article/view/826.